| 1. Value of 18F-FDG PET/CT in preoperative diagnosing and staging of extrahepatic cholangiocarcinoma |
Page:65—69 |
| 2. Value of 18F-FDG PET/CT SUVmax for preoperative assessment of primary tumor infiltration and metastases in patients with endometrial cancer |
Page:75—80 |
| 3. 18F-FDG PET/CT of primary hepatic paraganglioma: a case report |
Page:97—98 |
| 4. In vitro imaging study of E-selectin receptor-targetting ultrasound contrast agent |
Page:86—90 |
| 5. Diagnostic value of 18F-FDG PET/CT in the staging of extranodal NK/T-cell lymphoma |
Page:91—92 |
| 6. 18 F-FDG PET/CT imaging for secondary pulmonary alveolar proteinosis: a case report |
Page:95—96 |
| 7. Progress in nuclear molecular probes for noninvasive prostate cancer clinical imaging |
Page:103—107 |
| 8. Application of 18F-NaF PET/CT in patients with bone metastasis from prostate cancer |
Page:108—110 |
| 9. Application of 18F-FDG PET/CT in rheumatoid diseases |
Page:111—114 |
| 10. 18F-FDG PET/CT imaging on a case of multiple pheochromocytoma with increased fat metabolism |
Page:93—94 |
| 11. MRI features of pancreatic schwannoma: a case report |
Page:99—100 |
| 12. Pulmonary metastasis from thyroid cancer: easy but not simple |
Page:101—102 |
| 13. Value of early dynamic 18 F-FDG PET/CT |
Page:45—48 |
| 14. 18 F-FDG PET/CT in assessment of Tomita score for patients with spinal metastases |
Page:31—34 |
| 15. Biodistribution of 99 Tcm O-labeled MAG3-2-nitroimidazole hypoxia imaging agents with different spacers in S180 scarcoma-bearing mice |
Page:25—30 |
| 16. Preparation and biological evaluation of radiolabeled folate receptor-positive tumor agent 99 Tcm-(HYNIC-NHHN-FA) (EDDA) |
Page:15—19 |
| 17. SP94 peptide as a specific probe for hepatocellular carcinoma imaging |
Page:10—14 |
| 18. Preparation and bioevaluation of 111 In-DTPA-avastin for non-invasive tumor targeted imaging |
Page:5—9 |
| 19. Metabonomics and its application in thyroid diseases |
Page:49—52 |
| 20. 18 F-FDG PET/CT in staging and metabolic activity assessment of multiple myeloma |
Page:35—38 |
| 21. Preparation and biological evaluation of 111 In-triphenylphosphonium cations |
Page:20—24 |
| 22. Influence of discontinuance of methimazole and propylthiouracil on 24 h radioactive iodine uptake in normal rats |
Page:162—165 |
| 23. Clinical value of TSH-stimulated thyroglobulin in evaluation of metastasis from differentiated thyroid carcinoma after 131I treatment |
Page:153—156 |
| 24. Quantitative comparison of 68Ga-NGR and 18F-FDG uptake in well-differentiated hepatocellular carcinoma bearing mice |
Page:147—152 |
| 25. 68Ga-exendin-4 PET/CT for the localization of insulinomas |
Page:137—141 |
| 26. Application of 123/131I-MIBG in the diagnosis and treatment of pediatric neuroblastoma |
Page:173—176 |
| 27. Assessment of ventricular systolic synchrony and ventricular function with gated myocardial perfusion imaging in patients with chronic heart failure |
Page:157—161 |
| 28. Clinical value of 68Ga-PSMA-11 PET/CT in the diagnosis of castration-resistant prostate cancer |
Page:142—146 |
| 29. Research progress of redifferentiation of radioiodine-refractory differentiated thyroid carcinoma |
Page:579—583 |
| 30. Influence of different image processing methods on mensuration of cardiac function in myocardial perfusion imaging |
Page:564—567 |
| 31. Relationship between the initial change of Tg and outcome in differentiated thyroid carcinoma patients with pulmonary metastases after 131I treatment |
Page:555—558 |
| 32. Value of 131I SPECT/CT on the re-staging and recurrence risk stratification and its impact on subsequent treatment strategy in post-surgical patients with differentiated thyroid carcinoma |
Page:550—554 |
| 33. Statistical parametric mapping-based interhemispheric asymmetry analysis of 18F-FDG PET brain imaging in localization of unilateral temporal lobe epileptic foci |
Page:538—543 |
| 34. Progresses of radiopharmaceuticals in inflammation and infection imaging |
Page:584—588 |
| 35. Preparation of 68Ga-PSMA-617 and its microPET imaging in BGC-823 cell bearing mice |
Page:568—571 |
| 36. Comparison of RECIST1.1, PERCIST1.0, WHO and EORTC in the evaluation of treatment response in colorectal liver metastases after neoadjuvant chemotherapy |
Page:559—563 |
| 37. Gender differences of brain metabolic networks: a 18F-FDG PET study |
Page:544—549 |
| 38. Non-displaceable binding potential changes of striatal dopamine D2 receptors in patients with first-episode major depressive disorder and the correlation with clinical features |
Page:532—537 |
| 39. Diagnosis of brain tumor with multi-modality imaging of 11C-MET PET combined with functional MRI |
Page:527—531 |
| 40. Value of lactulose hydrogen breath test combined with radionuclide imaging in the diagnosis of small intestinal bacterial overgrowth |
Page:478—481 |
| 41. Impact of point spread function on image quality and SUV in FDG PET imaging |
Page:475—477 |
| 42. Experimental researches and immunoassay influence factors of calcitonin |
Page:511—513 |
| 43. Benefits of patients with differentiated thyroid carcinoma in different risk stratification from 131I therapy |
Page:506—510 |
| 44. Application of 18F-FDG PET/CT and other conventional imaging technologies in carcinoma of unknown primary site |
Page:502—505 |
| 45. Effects of miR106a on the proliferation, apoptosis and invasion of thyroid cancer cells in vitro |
Page:486—491 |
| 46. Preparation of folate-NOTA-Al18F targeting folate receptor and its microPET/CT imaging |
Page:482—485 |
| 47. Combined impacts of blood glucose level and glucose metabolism-related factors on liver 18F-FDG uptake |
Page:470—474 |
| 48. Characteristics of T-and NK/T-cell lymphomas with different pathological subtypes on 18F-FDG PET/CT |
Page:464—469 |
| 49. Relationship of PET/CT characteristic manifestations and pathology in ovarian sex cord-stromal tumor |
Page:460—463 |
| 50. Value of 18F-FDG PET/CT in staging of pancreatic cancer |
Page:456—459 |
| 51. Clinical value of dual-phase 18F-FDG PET/CT for differentiating pancreatic cancer from pancreatitis |
Page:449—455 |
| 52. Recent advances in radiotracers for apoptosis imaging |
Page:366—369 |
| 53. Progression in photoacoustic imaging for cancer diagnosis and therapy |
Page:361—365 |
| 54. Relationship between the peripheral dose and radioactive counts of 125I seeds detected by SPECT/CT |
Page:351—354 |
| 55. Imaging atherosclerosis model rabbits with 99Tcm-single chain antibody fragment against vascular cell adhesion molecule-1 |
Page:346—350 |
| 56. Application of amide proton transfer imaging in differentiating glioma from treatment effect |
Page:337—341 |
| 57. Diagnostic value of glomerular filtration rate, microalbuminuria, β2-microglobulin and cystatin C for renal function in patients with diabetic nephropathy |
Page:331—336 |
| 58. Predictive value for adverse cardiac events of left ventricular diastolic function measured by gated myocardial perfusion imaging |
Page:326—330 |
| 59. Multi-modality imaging in the patients with myocardial infarction after coronary artery bypass graft and autologous bone marrow stem cell transplantation |
Page:321—325 |
| 60. Development of Cerenkov signal enhancement by fluorescence excitation effect |
Page:240—242 |
| 61. PET/CT diagnostic procedure from a rare case of ovarian mixed germ cell tumor |
Page:234—236 |
| 62. Multiple myeloma in 99Tcm-DTPA renal scintigraphy: a case report |
Page:232—233 |
| 63. PET/CT imaging on a case of pancreatic tuberculosis |
Page:230—231 |
| 64. Assessment of effects of 7,8-dihydroxyflavone on the striatum in normal cynomolgus monkeys with 99TCm-TRODAT-1 SPECT/CT imaging |
Page:216—219 |
| 65. Effect of postoperative thyrotropin suppression on bone mineral density in postmenopausal women with differentiated thyroid carcinoma |
Page:212—215 |
| 66. A pilot study on the biodistribution pattern of 68Ga-DOTA-TATE in normal organs of adults |
Page:207—211 |
| 67. Characteristics of cerebral glucose metabolism on 18F-FDG PET imaging in patients with Parkinson's disease |
Page:193—197 |
| 68. Comparison on the diagnostic values of 18F-FDG and 18F-FLT PET/CT in patients with suspicious recurrence of glioma after multimodal treatment |
Page:198—201 |
| 69. Methods of suppressing physiological myocardial uptake in 18F-FDG imaging |
Page:305—307 |
| 70. Reconsideration of the role of viable myocardium in revascularization |
Page:301—304 |
| 71. A case of inflammatory myofibroblastic tumor originated from the greater omentum on 18F-FDG PET/CT imaging |
Page:297—298 |
| 72. Optimizing study of the gastrointestinal preparation methods before 18F-FDG PET/CT examination |
Page:294—296 |
| 73. Comparative study of arterial vulnerable plaque molecular imaging with novel molecular probes 99Tcm-Duramycin and 99Tcm-RGD in rabbit models |
Page:289—293 |
| 74. Localization and etiologic diagnosis of suspected pacemaker-related infection with 18F-FDG PET/CT |
Page:284—288 |
| 75. Enhancement with coronary artery calcification score in detection of coronary heart disease by myocardial perfusion SPECT imaging |
Page:274—278 |
| 76. Myocardial perfusion imaging evaluation of left ventricular volume and ejection fraction using a novel semi-conductor SPECT: comparison to conventional SPECT and cardiac MRI |
Page:269—273 |
| 77. Factors for the synthesis of 18F-MyoZone and myocardial tomography in normal swine |
Page:260—264 |
| 78. Patient-centered radionuclide imaging in cardiovascular diseases |
Page:257—259 |
| 79. Occult metastases from breast carcinoma: a case report |
Page:299—300 |
| 80. Comparative analysis of FDG PET SUVmax cutoff values in detection of mediastinal lymph node metastasis and hilar/intralobar lymph node metastasis in patients with non-small cell lung cancer |
Page:279—283 |
| 81. Cardiac neuroceptor imaging on acute myocardial ischemia model using 11C-methyldopamine |
Page:265—268 |
| 82. Development of PET agent for cardiac sympathetic nervous system |
Page:237—239 |
| 83. Optimal scan time of MRI with alpha-methyl-L-tryptophan superparamagnetic iron oxide nanoparticles for temporal lobe epilepsy |
Page:220—224 |
| 84. Comparison of 18F-FDG and 68Ga-DOTA-NOC PET/CT on the diagnosis of G3 neuroendocrine neoplasm |
Page:202—206 |
| 85. Comparison of different chemiluminecence immunoassay analyzers for determination of serum thyroid stimulating hormone in patients with suspicious subclinical hypothyroidism |
Page:342—345 |
| 86. Update and progress of the response-to-therapy assessment system in differentiated thyroid cancer |
Page:420—425 |
| 87. Feasibility of 99Tcm-3P4-RGD2 SPECT/CT imaging in evaluation of arterial plaque stability after atorvastatin intervention in rabbits |
Page:410—414 |
| 88. Influence of gender, age and weight on the cardiac functional parameters determined by gated myocardial SPECT imaging in patients with low-likelihood coronary heart disease |
Page:404—409 |
| 89. Clinical incremental values of extraosseous findings on CT during bone SPECT/CT imaging |
Page:400—403 |
| 90. Value of 99Tcm-Tilmanocept and 99Tcm-sulfur colloid SPECT/CT for the detection of sentinel lymph node in breast cancer patients |
Page:388—391 |
| 91. Estimation of patient radiation dose and risk from whole body 18F-FDG PET/CT examination |
Page:430—433 |
| 92. PET reporter gene imaging in cellular immunotherapy for cancer |
Page:426—429 |
| 93. Value of 99Tcm-MIBI SPECT/CT in pre-operative diagnosis of primary and secondary hyperparathyroidism |
Page:395—399 |
| 94. SPECT/CT evaluation for lumbago in post-lumbar spinal fusion patients |
Page:392—394 |
| 95. Evaluation of relationship between myocardial injury and left ventricular mechanical dyssynchrony using 99 Tcm-MIBI myocardial perfusion SPECT and 18 F-FDG myocardial metabolic PET imaging |
Page:623—626 |
| 96. Prognostic value of interim 18 F-FDG PET/CT in patients with natural killer/T cell lymphoma |
Page:618—622 |
| 97. Prognosis significance of 18 F-FDG PET/CT imaging in patients with postoperative esophageal cancer |
Page:607—612 |
| 98. Value of 18 F-FDG PET/CT for prognosis evaluation in small cell lung cancer with normal serum lac-tate dehydrogenase |
Page:601—606 |
| 99. Application of PET/CT in targeted therapy of breast cancer |
Page:660—663 |
| 100. Application and comparison of PET/CT, contrast enhanced CT and MRI in the clinical manage-ment of pancreatic cancer |
Page:654—659 |
| 101. Preparation and characteristics analysis of 5-carboxy fluorescein-dextran-coated superparamagnetic iron oxide nanoparticle |
Page:637—641 |
| 102. Preparation of 18 F-DPA-714 and its biodistribution in rodents |
Page:632—636 |
| 103. Protective effect of curcumin on glucose metabolism evaluated by 18 F-FDG microPET/CT in rat models of intracerebral hemorrhage |
Page:627—631 |
| 104. 18 F-FDG PET/CT for restaging, guiding therapeutic strategy and predicting prognosis in patients with postoperative colorectal cancer |
Page:613—617 |
| 105. Evaluation of relationship between myocardial injury and left ventricular mechanical dyssynchrony using 99 Tcm-MIBI myocardial perfusion SPECT and 18 F-FDG myocardial metabolic PET imaging |
Page:623—626 |
| 106. Prognostic value of interim 18 F-FDG PET/CT in patients with natural killer/T cell lymphoma |
Page:618—622 |
| 107. Prognosis significance of 18 F-FDG PET/CT imaging in patients with postoperative esophageal cancer |
Page:607—612 |
| 108. Value of 18 F-FDG PET/CT for prognosis evaluation in small cell lung cancer with normal serum lac-tate dehydrogenase |
Page:601—606 |
| 109. Application of PET/CT in targeted therapy of breast cancer |
Page:660—663 |
| 110. Application and comparison of PET/CT, contrast enhanced CT and MRI in the clinical manage-ment of pancreatic cancer |
Page:654—659 |
| 111. Preparation and characteristics analysis of 5-carboxy fluorescein-dextran-coated superparamagnetic iron oxide nanoparticle |
Page:637—641 |
| 112. Preparation of 18 F-DPA-714 and its biodistribution in rodents |
Page:632—636 |
| 113. Protective effect of curcumin on glucose metabolism evaluated by 18 F-FDG microPET/CT in rat models of intracerebral hemorrhage |
Page:627—631 |
| 114. Clinical application and advance of regadenoson stress myocardial perfusion imaging |
Page:815—818 |
| 115. 99Tcm-MIBI dual-phase SPECT/CT in localization of intrathyroidal parathyroid in patient with secondary hyperparathyroidism: a case report |
Page:795—796 |
| 116. In situ and ectopic parathyroid adenoma: a case report of 99Tcm-MIBI SPECT/CT imaging |
Page:793—794 |
| 117. 18F-FDG PET/CT imaging on a case of papillary thyroid carcinoma with undifferentiated pleomorphic sarcoma |
Page:791—792 |
| 118. Factors influencing the outcome of the first 131I radiotherapy in patients with papillary thyroid carcinoma after total thyroidectomy |
Page:777—782 |
| 119. Radiological features of invasive adenocarcinoma presenting as pure ground-glass nodules |
Page:753—757 |
| 120. The state of the art of tumor molecular imaging targeting PD-1/PD-L1 pathway |
Page:809—814 |
| 121. PET/fMRI for precise localization of abnormal brain activity: a mini review |
Page:802—808 |
| 122. Addison disease caused by adrenal tuberculosis: a case report |
Page:799—801 |
| 123. 18F-FDG PET/CT imaging for primary pulmonary biphasic synovial sarcoma: a case report of misdiagnosis |
Page:797—798 |
| 124. Complementary value of CT coronary angiography combined with myocardial perfusion SPECT in diagnosing coronary artery stenosis |
Page:789—790 |
| 125. Establishment of an acquired tamoxifen-resistant human breast cancer cell line and its mechanism of 18F-FDG uptake reduction |
Page:783—788 |
| 126. Diagnostic value of neck ultrasonography and 18F-FDG PET/CT imaging during the follow-up of differentiated thyroid carcinoma patients with elevated serum TgAh |
Page:772—776 |
| 127. Prognostic value of rest gated myocardial perfusion SPECT imaging in male patients with ST-segment elevation myocardial infarction |
Page:767—771 |
| 128. Pulmonary high-resolution CT and radionuclide pulmonary perfusion/ventilation scan in pediatric patients with bronchiolitis obliterans |
Page:763—766 |
| 129. 18F-FDG uptake and clearance in the amygdala and hippocampus in patients with first-episode depression |
Page:758—762 |
| 130. Progress of nanoprobes for cancer diagnosis and treatment |
Page:726—729 |
| 131. Prognostic value of 18 F-FDG PET/CT in patients with limited-stage small cell lung cancer |
Page:694—699 |
| 132. A novel integrinαvβ3-targeted isoDGR probe for SPECT/CT imaging of glioma |
Page:689—693 |
| 133. Dual-modality imaging-guided sonodynamic therapy with DVDMS-Mn-loaded liposomes |
Page:685—688 |
| 134. In vivo characterization of a novel Cerasome based multi-modality imaging probe |
Page:680—684 |
| 135. Advances in CT-guided 125 I seed implantation on residual or relapsing metastatic cervical and medi- astinal lymph nodes |
Page:738—742 |
| 136. Recent progress of 89 Zr tracers for PET imaging |
Page:733—737 |
| 137. Research progress on the radio-synthesis of PET probes in microfluidic chips |
Page:730—732 |
| 138. Utility of 18 F-FDG PET/CT in early detection of radiation-induced heart disease in Beagle dogs |
Page:710—713 |
| 139. Efficacy and influential factors of post-resection 131 I therapy on metastases from differentiated thy- roid carcinoma |
Page:705—709 |
| 140. Diagnostic value of 18 F-FDG PET/CT for hepatic epithelioid hemangioendothelioma |
Page:700—704 |
| 141. 68Ga-radiopharmacueticals development: advances and opportunities of nuclear medicine |
Page:129—131 |
| 142. Characteristics of neuroendocrine neoplasm metastasis in somatostatin receptor PET/CT imaging: a retrospective analysis |
Page:132—136 |
| 143. 68Ga-exendin-4 PET/CT for the localization of insulinomas |
Page:137—141 |
| 144. Clinical value of 68Ga-PSMA-11 PET/CT in the diagnosis of castration-resistant prostate cancer |
Page:142—146 |
| 145. Quantitative comparison of 68Ga-NGR and 18F-FDG uptake in well-differentiated hepatocellular carcinoma bearing mice |
Page:147—152 |
| 146. Clinical value of TSH-stimulated thyroglobulin in evaluation of metastasis from differentiated thyroid carcinoma after 131I treatment |
Page:153—156 |
| 147. Assessment of ventricular systolic synchrony and ventricular function with gated myocardial perfusion imaging in patients with chronic heart failure |
Page:157—161 |
| 148. Influence of discontinuance of methimazole and propylthiouracil on 24 h radioactive iodine uptake in normal rats |
Page:162—165 |
| 149. Additional value of 18F-FDG PET/CT delayed imaging in the diagnosis of gastric cancer |
Page:166—167 |
| 150. 131I therapy for Graves disease in the right thyroid lobe of a patient with the left lobe and isthmus hemiagenesis |
Page:168—169 |
| 151. Comprehensive treatment for bone metastasis from follicular thyroid carcinoma with no 131I uptake:a case report |
Page:169—170 |
| 152. Small cell lung cancer with paraneoplastic syndrome: a case report |
Page:171—172 |
| 153. Application of 123/131I-MIBG in the diagnosis and treatment of pediatric neuroblastoma |
Page:173—176 |
